From Pilot to Program: How BioSqueeze Validates New Biomineralization Applications

IMPORTANT DISTINCTION: This framework applies to emerging applications. BioSqueeze well integrity is already an established commercial solution with standardized procedures and reliable, repeatable field results.

Emerging subsurface technologies often face the same commercialization challenge. A promising mechanism is identified, laboratory results are encouraging, a field opportunity appears, and a treatment is performed. Then the difficult question arrives: what did the pilot actually prove?

A production increase is encouraging, but was it caused by the treatment? A reduction in water or solids is valuable, but will the result persist? A technically successful treatment may still be too complicated, too expensive, or too candidate-dependent to become a repeatable commercial service.

The difference between a field experiment and a commercial field trial is discipline.

Start With the Right Context: Proven Platform, New Applications

For BioSqueeze, field validation does not mean starting over or reproving the underlying technology. In well integrity, biomineralization is already an established commercial solution. BioSqueeze has developed standardized operating procedures, treatment-design practices, manufacturing and quality systems, field-execution processes, and a body of experience that produces reliable, consistent results across repeat deployments.

The pilot-to-program framework becomes relevant when that proven platform is extended into a new engineering application.

Applications such as waterflood conformance, fines migration and sand control, refracturing zonal isolation, and CO₂ containment use the same underlying biomineralization capabilities, but each introduces a different treatment objective, target geometry, monitoring strategy, and economic case.

The question is not whether BioSqueeze can reliably mineralize subsurface pathways. The question is where that proven capability can create repeatable value in a new application.

That is what a disciplined field trial is designed to answer.

Start With the Engineering Problem, Not the Treatment

The strongest field trials begin before a treatment design is created. They begin by defining the engineering problem.

Consider a waterflood pattern where an injector appears to communicate directly with an offset producer. Increasing injection is producing more water, but little corresponding oil response.

The pilot objective should not simply be “test biomineralization for conformance.” A more useful objective would be: reduce conductivity through the dominant injector-producer pathway so that a greater percentage of injected water can access unswept reservoir volume.

The first objective tests a technology. The second tests an engineering hypothesis.

The same principle applies across emerging applications. For a refracturing candidate, the hypothesis may be that depleted legacy fractures are capturing stimulation fluid that would otherwise create new reservoir contact. For a fines-control candidate, the hypothesis may be that instability at grain contacts is generating mobile formation material that progressively restricts productivity.

For a CO₂ application, the hypothesis may be that a preferential fracture or high-permeability pathway is causing premature breakthrough or poor gas retention.

Before designing a treatment, the operator and BioSqueeze should agree on three things:

If those questions cannot be answered, more diagnostics may be needed before a field trial begins.

• What is happening?
• Why do we believe it is happening?
• What should change if the treatment works?

Step 1: Establish a Defensible Baseline

A pilot needs a starting point. Without one, even an impressive post-treatment result can be difficult to interpret.

The baseline should capture the variables most closely connected to the operating problem rather than every piece of available data.

Waterflood conformance

• Injection rates and pressures
• Producer water cut and oil response
• Injector-producer communication
• Tracer behavior or injection profiles
• Previous conformance treatments and results

Fines migration or sand control

• Produced-solids volumes and characteristics
• Production rate and pressure behavior
• Cleanout frequency
• Acid or chemical-treatment history
• Equipment failures associated with solids

Refracturing

• Original completion design
• Production and pressure depletion history
• Offset communication
• Previous stimulation data and fracture diagnostics
• Planned refrac design and economic forecast

CO₂ containment

The objective is to establish what the system was doing before treatment and create a credible reference against which post-treatment performance can be evaluated.

• Injection volumes and pressure
• Gas-oil ratio and recycling volumes
• Breakthrough timing
• Offset communication
• Tracer or pressure-response data

Step 2: Define the Treatment Target

Knowing that a problem exists is different from knowing where to treat it. A successful field trial needs a target.

Injection profiles, tracers, pressure interference, production logging, offset-well response, completion history, and reservoir characterization can all help narrow the target.

This is where an established BioSqueeze capability becomes especially relevant: placement before mineralization. Low-viscosity treatment fluids can access connected pathways before calcium carbonate is formed in place. But that advantage only matters if the treatment can reach the intended target, so accessibility must be part of the pilot hypothesis.

• A dominant fracture
• A thief zone or high-permeability interval
• A legacy fracture network
• A near-wellbore region experiencing fines instability
• A preferential pathway connecting wells

Step 3: Define Success Before the Treatment

Success criteria should never be created after seeing the result. Before field execution begins, the operator and BioSqueeze should agree on the primary performance metric, secondary indicators, evaluation period, and what would constitute both technical and commercial success.

Those definitions may not be identical. A conformance treatment might successfully reduce communication through a thief zone, demonstrating technical success. But if the intervention does not improve oil recovery, reduce water-handling expense, or create another meaningful operating benefit, the commercial case may remain uncertain.

A useful pilot measures both the engineering response and the economic consequence.

• Waterflood conformance: reduced offset water production, changed injection profile, delayed tracer response, improved oil response, lower water-handling cost.
• Refracturing isolation: higher breakdown pressure, evidence of new fracture initiation, reduced communication with depleted intervals, improved post-refrac production.
• Fines stabilization: lower produced-solids volumes, longer time between cleanouts, stabilized productivity, reduced equipment damage.
• CO₂ containment: delayed breakthrough, improved gas retention, reduced recycling requirements, changed injection profile, improved CO₂ utilization.

Step 4: Design the Smallest Pilot That Can Answer the Question

Early field trials should be ambitious enough to produce meaningful data, but not larger than necessary. The objective is not to maximize treatment volume. It is to maximize learning.

A disciplined pilot should isolate the variables that matter most: candidate quality, placement, treatment volume, reaction behavior, operational execution, performance response, and durability.

This often favors a carefully selected and well-instrumented candidate over a larger program with insufficient diagnostics. One clear technical answer can be more valuable than several treatments whose results cannot be separated from normal reservoir variability.

The first deployment should improve the second. The second should improve candidate selection or treatment design. The third should begin testing repeatability.

Step 5: Monitor What Happens After the Pumps Stop

The treatment itself may take hours or days. The useful information can develop over months. Post-treatment monitoring should therefore be designed before field execution and matched to the mechanism being tested.

Monitoring should also distinguish immediate changes from durable ones. A temporary pressure response may indicate successful placement. A sustained response months later begins to demonstrate durability. A repeatable response across multiple candidates begins to establish a commercial application.

• Production response
• Injection rate and pressure
• Injection profile
• Water cut or gas-oil ratio
• Produced solids
• Offset-well pressure response
• Tracer response
• Refracturing pressure behavior
• Intervention frequency and operating expense

Step 6: Treat Every Pilot as a Data-Generation Opportunity

A field trial does not need to achieve every performance target to produce value. A technically disappointing result can still improve the application if the pilot was designed to generate useful data.

Perhaps the fluids reached the intended interval but treatment volume was insufficient. Perhaps mineralization occurred, but the selected pathway was not the primary cause of the production problem. Perhaps the treatment worked technically, but the candidate did not contain enough remaining value to generate an attractive economic return.

Those are very different outcomes. A disciplined pilot allows them to be separated and converts each deployment into better candidate-selection criteria, treatment-design rules, volume estimates, operating procedures, diagnostic requirements, and economic thresholds.

A poor pilot produces a yes-or-no result. A good pilot improves the next treatment regardless of outcome.

From a Successful Pilot to a Commercial Program

A single successful treatment does not create a new commercial business. Repeatability does.

The transition from pilot to program occurs when enough field evidence exists to define an application envelope.

Which candidates are most likely to respond?

Instead of broadly searching for problem wells, operators can screen assets against increasingly specific technical criteria.

How should treatments be designed?

Treatment volumes, placement strategy, isolation requirements, and operating parameters begin to fall within predictable ranges.

How should success be measured?

The most useful diagnostics and performance metrics become standardized.

How durable is the result?

Longer-term monitoring begins establishing expected treatment life and retreatment requirements.

Do the economics work repeatedly?

The commercial question shifts from whether one treatment generated value to whether the application can deliver attractive returns across a portfolio of candidates.

At that point, the conversation with an operator changes. The opportunity is no longer “Would you like to test biomineralization?” It becomes: “These wells match the characteristics of candidates where this application has performed well. Here is the treatment approach, expected outcome, and economic case.”

Well Integrity Shows What the Destination Looks Like

BioSqueeze well integrity provides the model for where successful application development can lead. The technology is already deployed as a proven commercial solution with established procedures, trained execution practices, defined treatment workflows, and reliable, repeatable results.

New applications are not at that same maturity level yet. That is precisely why the field-validation process matters. The goal is to move each promising application through a disciplined progression: field trial, application validation, and eventually a predictable commercial program.

The proven well-integrity business also provides an important advantage during that process. BioSqueeze is not building the manufacturing system, quality system, field-delivery capability, or fundamental biomineralization know-how from scratch each time. New application development can build on an established operating platform and focus learning on what is genuinely new: the target, treatment objective, performance criteria, and economics.

What Makes a Strong Field-Validation Partner?

The best opportunities involve more than a good well. They involve an operator willing to develop the application collaboratively.

BioSqueeze brings the proven biomineralization platform, treatment-design capability, field execution experience, manufacturing and quality systems, and lessons generated through commercial well-integrity deployments.

The goal is not simply to perform one treatment. It is to determine whether the problem represents a repeatable application that can eventually be deployed across an asset, basin, or operating portfolio.

• A clearly defined operating problem
• Access to relevant subsurface and production data
• Internal technical expertise
• A candidate with meaningful economic upside
• The ability to monitor performance
• Agreement on success criteria
• Willingness to capture and apply what is learned

Build the Program Into the Pilot

Biomineralization offers a different way to approach difficult subsurface engineering problems. Instead of forcing a preformed material into an inaccessible pathway, mineral can be created inside the pathway itself.

For well integrity, BioSqueeze has already moved from pilot to program. The technology is established, the operating procedures are defined, and the commercial results are repeatable.

For emerging applications, the objective now is to use that proven foundation to develop the next generation of commercial biomineralization solutions through disciplined field validation.

That requires the right candidate, a defensible baseline, a defined target, pre-established success criteria, a monitoring plan, and a process for turning what is learned from one deployment into a better next deployment.

A pilot proves what happened once. A program begins when you understand why it happened—and can design it to happen again.

BioSqueeze is evaluating field-validation partnerships for waterflood conformance, refracturing zonal isolation, fines migration and sand control, and CO₂ containment. Operators with a well or pattern that presents a measurable flow-control or formation-stability problem are invited to submit an opportunity for technical review.

Info@BioSqueeze.com | 406.616.3440